Abstract
Introduction 47 48
Life on earth follows a daily 24-hour rhythm that impacts on a range of behaviors 49 such as activity and feeding. Alterations in physiology that peak and trough in a 50 24 h timescale are classified as circadian and are caused by oscillations in the 51 proteins of the molecular circadian clock (9, 18) . Circadian oscillations of immune 52 mediators coincide with the activity and trafficking of the immune system (12), 53 helping to promote tissue recovery and handle microbial threats more efficiently 54
(35). Disruption of circadian rhythms has been linked to inflammatory pathologies 55
and recent studies have identified the critical importance of the 24 h cycle on 56 immune function (19) . 57 BMAL1 is the main orchestrator of the molecular clock, as it is the only 58 single clock gene deletion that leads to complete ablation of the molecular clock, 59
resulting in a loss of all rhythmic behavioral activity (5). The molecular clock 60 exists in immune cells (36) including macrophages, where it plays key functions 61 involving control of inflammatory responses (14, 24) . Use of a genetic approach 62
However no study has examined BMAL1 deficient immune cells in the context of 70 asthma. Since alveolar macrophages (AMs) are key orchestrators of pulmonary 71 immune responses (21) and have crucial role in a mouse model of asthma (46), 72 we have decided to use myeloid cell-specific deletion of Bmal1. Macrophages 73 from mice lacking BMAL1 in myeloid cells exhibit augmented responses to LPS 74 (10). Moreover these mice have lost circadian rhythm of inflammatory 75 monocytes, exhibit increased CCL2 production, and decreased survival in 76 response to bacterial infection (31). The significance of BMAL1 in structural or 77
immune cells has never been tested in a Th2 type disease such as asthma. 78
Asthma symptoms worsen at night, particularly in the early hours of the 79 morning (13). Lung function fluctuates in healthy individuals over 24 h period and 80 these fluctuations are even more pronounced in asthmatics (26). These changes 81 and airway challenge, sample collection was performed in the morning to ensure 119 high BMAL1 expression. These acute allergic inflammation protocols resulted in 120 eosinophilic accumulation measured in bronchoalveolar lavage fluid (BALF). 121
Isolation of cells from BALF 122
Lung lavage was performed according to a previously described protocol (20) 123 employing 800-μl aliquots of sterile PBS/2 mM EDTA (pH 7.2) until a BALF 124 volume of 3 ml was recovered. Total cells from BALF were suspended in PBS 125 and counted by light microscopy. Aliquots were taken to prepare cytospins for 126 H&E staining and differential counting, which was performed on 100 cells from 127 each mouse. 128 
Isolation of cells from lung digests and cell sorting

RNA Isolation and Quantitative Real-Time PCR 150
RNA extraction was performed using the RNeasy Mini Kit (QIAGEN), and cDNA 151 was generated using the Applied Biosystems High-Capacity cDNA Archive Kit. 
ELISA 165
The quantification of murine IL-5 protein was performed by commercially 166 available ELISA kit following the instructions of the manufacturer (R&D Systems, 167
Minneapolis, MN). 168
Statistical analysis 169
Data are presented as mean ± SEM. Statistical significance was analyzed using 170 the GraphPad Prism 5.0 statistical program (GraphPad Software, La Jolla, CA). 171
Comparisons between two experimental groups were performed using the 172 We first examined allergic lung inflammation in mice where BMAL1 is removed 179 from the myeloid lineage (BMAL1-LysM -/-) (10), using the previously described 180 (46) Ovalbumin (OVA) induced model of acute lung inflammation (Fig. 1A ) 181 resulting in predominantly eosinophilic infiltration. Mice were subjected to the 182 OVA asthma model and lungs were examined for leukocyte infiltration at day 9 of 183 the protocol. BMAL1-LysM -/-mice compared to wild types had significantly higher 184 amount of leukocytes in lavage fluid (Fig. 1B) . Upon histological examination we 185 have determined that eosinophils were significantly higher in BALF from BMAL1-186 LysM -/-lungs, while AM numbers remained unchanged ( Fig. 1C and D) . (Fig. 3B) . Expression of BMAL1 in eosinophils from both genotypes 208 was very low and not significantly different between the two genotypes (Fig. 3B) . 209
Eosinophils from BMAL1-LysM -/-lungs had higher expression of major airway 210 mucin-muc5ac compared to WT controls, while AMs from both genotypes lacked 211 muc5ac expression (Fig. 3B) . High muc5ac expression correlated with low 212 BMAL1 (Fig. 3B ). These data indicates that eosinophils from asthmatic BMAL1-213 stimulated with LPS to asses chemokines relevant to asthma, namely CCL2 and 228 CXCL10 (Fig. 4) . Expression levels of both CCL2, responsible for recruitment of 229 monocytes in allergic inflammation (1), and CXCL10, which is known to activate 230 of eosinophils (42) Additionally blood eosinophils from healthy and allergic subjects were 252 demonstarted to have ciracadian variations, which include rhythmic expression of 253 BMAL1 (2). We wanted to examined the characteristics of functional eosinophils 254 which left circulation and entered lung tissue. Although lung eosinophila is a 255 hallmark of allergic asthma, eosinophils are extremely rare in the lung at baseline 256 (34). Therefore we were able to assess BMAL1 expression only in asthmatic 257 mice. Since BMAL1 levels in eosinophils were very low and not different between 258 BMAL1-LysM -/-and wild type mice we concluded that eosinophil numbers and 259 phenotype is controlled indirectly by macrophages or possibly other myeloid 260 cells. Neutrophils being another relevant myeloid cell type can also be invloved,however since they were found in BALF in low numbers we were not able to 262 examine their phenotype, and therfore focused on alveolar macrophages. We 263 therfore speculate that a major immune mediator candidate for crosstalk between 264 macrophages and eosinophils resposible for regulating eosinophil numbers and 265 fuction is IL-33. In vivo as well as in vitro IL-33 induces IL-5 production and 266 eosinophila (37) and recently was shown to be critical for eosinophil development 267 and homeostasis (23). Future studies should also assess numbers and 268 phenotype of Type 2 innate lymphoid cells in asthmatic BMAL1-LysM The OVA model of food allergy was a first study demonstrating that antigen 280 exposure in the late light period induced more severe symptoms of disease (45) . 281
Our OVA model examined allergic asthma, which is another Th2 type of disease, 282 and similar to food allergy is affected significantly by environmental stimuli, whichalter molecular clock gene expression (40). Our study therefore identifies BMAL1 284 as potential target for therapeutic intervention. 285
Data presented in this study highlight the relevance of myeloid cells in allergic 286 asthma and provide a good rationale to examine circulating myeloid cells from 287 asthmatic patients. Studying peripheral blood cells provides a readily accessible 288 way to evaluate expression of peripheral clock genes in humans (6). Oscillations 289 in molecular clock genes in peripheral blood mononuclear cells have been 290
reported previously in human populations (3, 25, 43) , and can serve as an 291 alternative to future animal asthma models in dissecting chronobiology of 292 asthma. As depicted in Fig. 4 BMAL1 has the capacity to inhibit both LPS and IL-293 4 driven macrophage responses, therefore we expect that a broad range of 294 inflammatory disorders will be affected by BMAL1 expression. This data identifies 295 BMAL1 as a very potent immune regulator and future studies will likely discover 296 further functions for BMAL1 outside the clock. 297
BMAL1 controls fundamental aspects of the innate immune response (8). In fact, 298
8% of the macrophage transcriptome undergoes a circadian variation (24). 299
Importantly, the TLR4 pathway, including genes involved in all aspects of the 300 TLR4 response, is under circadian control leading to clock-controlled enhanced 301 sensitivity and immunosurveillance (8). This includes chemokines and leukocyte 302 trafficking, which were exacerbated in our model. LPS is known to exacerbate 303 asthma features (27, 39), therefore BMAL1 may negatively regulate asthma by 304 inhibition of LPS responses. Although asthma features in humans are 305 exacerbated at night, in contrast to humans mice are nocturnal and active at 
